Triomics is at the forefront of clinical research technology, with a focus on interoperability and AI. Our technology helps research staff at hospitals access and use EHR data for automated data entry into EDCs, identification of AEs/SAEs from clinical notes, and pre-screening of patients against trial eligibility criteria. We have raised over $14 million from leading venture capital firms such as Lightspeed, Nexus, Y Combinator, and General Catalyst.

Bio-Avilabiltity & Bio-Equivalance Studies in Human Plasma using Solid Phase Extraction.Drugs Included in the Studies (Dapagliflozlin, Sitagliptin, Mesalamine, & Posaconazole)

Estimation of various types of phytochemicals such as Gallic Acid, chebulagic acid, ellagic acid etc using HPLC methods